Calling on the #CLLsm community! This research focuses on BTK inhibitor resistance in #CLL patients & overcoming with BTK degraders from @Nurix_Tx! In collaboration with @MSKCancerCenter and published @ScienceMagazine! Read more and vote here https://t.co/4f016oWNNg #lymsm#leusm